Even when started in the first month after renal transplantation, angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are effective and safe.
Richard N. Formica, Jr., MD, and colleagues at Yale University School of Medicine, in New Haven, Connecticut, reported results of their retrospective assessment of ACE inhibitors and ARBs here November 1 at the 35th Annual Meeting of the American Society of Nephrology (ASN).
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!